(FY)Dec 31, 2023 | |
---|---|
Operating Cash Flow (Indirect Method) | |
Cash flow from continuing operating activities | -12.53M |
Net income from continuing operations | --9.89M |
Operating gains losses | --13.51K |
Depreciation and amortization | --2.72M |
Other non cash items | --180.19K |
Change In working capital | ---25.33M |
-Change in inventory | ---40.73M |
-Change in prepaid assets | ---25M |
-Change in payables and accrued expense | --10.75M |
-Change in other current assets | ---109.92K |
-Change in other current liabilities | ---131.66K |
-Change in other working capital | --29.88M |
Cash from discontinued investing activities | |
Operating cash flow | ---12.53M |
Investing cash flow | |
Cash flow from continuing investing activities | -114.24M |
Net PPE purchase and sale | ---114.24M |
Cash from discontinued investing activities | |
Investing cash flow | ---114.24M |
Financing cash flow | |
Cash flow from continuing financing activities | 146.15M |
Net issuance payments of debt | --105.61M |
Net common stock issuance | --42.36M |
Net other financing activities | ---1.82M |
Cash from discontinued financing activities | |
Financing cash flow | --146.15M |
Net cash flow | |
Beginning cash position | --2.07M |
Current changes in cash | --19.38M |
Effect of exchange rate changes | ---2.45M |
End cash Position | --19M |
Free cash flow | ---126.77M |
Currency Unit | USD |
No Data